Has Convalescent Plasma Therapy Hesitancy Increased COVID-19 Mortality?-Reference-Cited by-同舟云学术

Has Convalescent Plasma Therapy Hesitancy Increased COVID-19 Mortality?

Published:2021-01 Issue:01 Volume:10 Page:42-45
ISSN:2278-330X
Container-title:South Asian Journal of Cancer
language:en
Short-container-title:South Asian J Cancer

Author:

Parikh Purvish M.¹,Sood T.²,Agarwala V.³,Kate S.⁴

Affiliation:

1. Mumbai Oncocare Centers, Mumbai, Maharashtra, India

2. Department of Medical Oncology, Manipal Hospital, Bengaluru, Karnataka, India

3. Department of Medical Oncology, Narayana Superspeciality Hospital, Kolkata, West Bengal, India

4. Department of Medical Oncology, HCG Manavata Cancer Center, Nashik, Maharashtra, India

Abstract

AbstractWe bring to you our viewpoint and a snapshot of the journey of convalescent plasma therapy (CPT) in the management of ongoing coronavirus disease 2019 (COVID-19) pandemic. We also discuss how best to use the updated data on this important treatment option and maximize benefit for our patients, thereby saving lives, especially in resource constraint settings.

Publisher

Georg Thieme Verlag KG

Subject

Cancer Research,Oncology

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0041-1733351.pdf

Reference16 articles.

1. Resurgence of COVID-19 in India—challenges and solutions;P M Parikh;Int J Med Sci,2021

2. Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: a randomized clinical trial;L Li;JAMA,2020

3. A randomized trial of convalescent plasma in Covid-19 severe pneumonia;V A Simonovich;N Engl J Med,2021

4. Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial;A Agarwal;BMJ,2020

5. Convalescent plasma therapy for COVID-19 still has the potential to save lives—the ICMR PLACID study dissected;K K Gundavda;Int J Molecular & Immuno Oncology,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Multi-Center, Open-Label, Randomized Controlled Trial to Evaluate the Efficacy of Convalescent Plasma Therapy for Coronavirus Disease 2019: A Trial Protocol (COVIPLA-RCT);Life;2022-06-08